Feng Q, Yu M, Kiviat NB: Molecular biomarkers for cancer detection in blood and bodily fluids. Crit Rev Clin Lab Sci 43, 497-560 (2006).Quinhua, F., Mujun, Y., and. Kiviat, N.B.: Molecular biomarkers for cancer detection in blood and bodily fluids. Critical reviews in clinical ...
But there was no significant association between treated and control samples related to the other four cancer markers and blood factors These results emphasized that DMBA-induced breast cancer in SD rat strains is a suitable model for biological studies on breast cancers....
Described herein are markers for hematological cancers, such as lymphoma, and uses of such markers in methods, kits, and devices. Th invention provides methods for identifying mutations associated with certain types of cancers. Mutations are identified in cancerous B cell or T cells, e.g. somati...
Use of molecular markers in urine, tissue or blood offers potential opportunities to improve understanding of bladder cancer biology which may help identif
Blood-derived DNA methylation markers of cancer risk. Advances in experimental medicine and biology 754, 233-252, doi: 10.1007/978-1-4419-9967-2_12 (2013).Marsit C, Christensen B. Blood-derived DNA methylation markers of cancer risk. Adv Exp Med Biol. 2013; 754:233-252. [PubMed: ...
Bladder cancer is one of the malignancies for which extensive information regarding molecular pathogenesis and genetic predictors of natural history as well as response to various modalities of treatment based on molecular profile is available. As more prognostic markers are being investigated in clinical...
Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data Using multiple datasets from real-world evidence and completed trials, a machine learning model using routine blood and clinical data is shown to be predictive of patient response to immune...
9) All analyses for each patient must be performed in the same laboratory, using the same technique (standard, expert agreement). 10) Calcitonin and carcinoembryonic-antigen are serum markers for the monitoring of medullary thyroid cancer and allow the detection of recurrent disease (standard). ...
There is a need for sensitive and specific diagnostic and prognostic molecular markers which can monitor early patterns of gene expression in non-invasive exfoliated colonocytes shed in the stool, and aggression in carcinoma cells in blood of resected colorectal cancer patients. RNA-based detection ...
Integration of clinical, pathological, radiological, and transcriptomic data improves prediction for first-line immunotherapy outcome in metastatic non-small cell lung cancer Overall survival in metastatic non-small cell lung cancer is improved by immunotherapy but individual responses widely vary, and pre...